Recent Advances in Drug Delivery and Formulation (RADDF)
Journal Descriptions
Recent Advances in Drug Delivery and Formulation is a quarterly peer‑reviewed journal published by Bentham Science Publishers that highlights significant scientific and technological advancements in the fields of drug delivery systems and pharmaceutical formulation. The journal covers a wide spectrum of topics, including preformulation studies, formulation design and optimization, manufacturing technologies, biopharmaceutics and regulatory science for both traditional chemically derived drugs and emerging biologics. Its multidisciplinary approach brings together areas such as pharmaceutical nanotechnology, quality‑by‑design (QbD) strategies, process analytical technologies (PAT), simulation and modeling, and regulatory considerations including biosimilars and biowaiver frameworks. By publishing original research, authoritative reviews, technical notes and guest‑edited thematic issues, the journal provides a platform for sharing innovative formulation strategies, mechanistic insights and practical solutions that address real‑world challenges in drug performance, stability and therapeutic delivery. It supports the dissemination of both fundamental scientific discoveries and translational approaches that can accelerate product development and improve clinical outcomes. Serving academic researchers, pharmaceutical scientists, formulation experts and regulatory professionals, Recent Advances in Drug Delivery and Formulation emphasizes timely and impactful contributions that facilitate knowledge exchange across disciplines and help advance the design, evaluation and regulatory acceptance of next‑generation pharmaceutical products. The journal’s quarterly frequency ensures a regular flow of current perspectives and emerging trends in this rapidly evolving scientific landscape.
Recent Advances in Drug Delivery and Formulation (RADDF) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Pharmacology (medical), Pharmacology (nursing), Pharmacy, formulation development, biopharmaceutics, manufacturing technologies and regulatory science for both small‑molecule drugs and biomolecules, process analytical technologies , Online or Print , Quarterly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2667-3886, E-ISSN: 2667-3878, Established: 2021,
- Does Not Provide Crossref DOI
-
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE